We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| DuPont de Nemours Inc | NYSE:DD | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.08 | -0.10% | 77.67 | 78.38 | 77.14 | 78.38 | 2,391,433 | 01:00:00 |
From May 2019 to May 2024
By Dave Sebastian
DuPont de Nemours Inc. said it sees sales rising roughly 8% in 2021 to between $15.4 billion and $15.6 billion after it reported higher profit and sales for the fourth quarter.
The Wilmington, Del.-based materials and chemicals company sees adjusted earnings of $3.30 a share to $3.45 a share for the full year, reflecting better operating earnings before interest, taxes, depreciation and amortization, lower interest expense and the benefit of a lower share count, Finance Chief Lori Koch said Tuesday.
Ms. Koch said the company sees first-quarter sales rising about 4% to between $3.75 billion to $3.85 billion. It expects adjusted earnings of 75 cents a share to 77 cents a share for the quarter, she said.
The company will classify the nutrition and biosciences segment as discontinued operations starting the first quarter, it said.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
February 09, 2021 06:33 ET (11:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year DuPont de Nemours Chart |
1 Month DuPont de Nemours Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
